Gene therapy shines light on congenital stationary night blindness for future cures | Journal of Translational Medicine
Masland RH. The fundamental plan of the retina. Nat Neurosci. 2001;4:877–86.
Google Scholar
Baden T, Euler T. Retinal physiology: Non-Bipolar-Cell excitatory drive in the inner retina. Curr Biol. 2016;26:R706–8.
Google Scholar
Zeitz C. Molecular genetics and protein function involved in nocturnal vision. Expert Rev Ophthalmo. 2007;2:467–85.
Google Scholar
Russell S, Bennett J, Wellman JA, Chung DC, Yu ZF, Tillman A, Wittes J, Pappas J, Elci O, McCague S, et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet. 2017;390:849–60.
Google Scholar
Kim AH, Liu P-K, Chang Y-H, Kang EY, Wang H-H, Chen N, Tseng Y-J, Seo GH, Lee H, Liu L, et al. Congenital stationary night blindness: clinical and genetic features. Int J Mol Sci. 2022;23:14965.
Google Scholar
Katta M, de Guimaraes TAC, Fujinami-Yokokawa Y, Fujinami K, Georgiou M, Mahroo OA, Webster AR, Michaelides M. Congenital stationary night blindness: structure, function and Genotype-Phenotype correlations in a cohort of 122 patients. Ophthalmol Retina. 2024;8:932–41.
Google Scholar
Zeitz C, Friedburg C, Preising MN, Lorenz B. Overview of congenital stationary night blindness with predominantly normal fundus appearance. Klin Monbl Augenheilkd. 2018;235:281–9.
Google Scholar
Azhar Baig HM, Ansar M, Iqbal A, Naeem MA, Quinodoz M, Calzetti G, Iqbal M, Rivolta C. Genetic analysis of consanguineous Pakistani families with congenital stationary night blindness. Ophthalmic Res. 2022;65:104–10.
Google Scholar
Robson AG, Frishman LJ, Grigg J, Hamilton R, Jeffrey BG, Kondo M, Li S, McCulloch DL. ISCEV standard for full-field clinical electroretinography (2022 update). Doc Ophthalmol. 2022;144:165–77.
Google Scholar
Bearse MA. Jr. Principles and practice of clinical electrophysiology of vision. Optom Vis Sci. 2007;84:825. 2nd ed.
Google Scholar
Shanmugam P, Mohankumar A, Mohan S, Rajan M, Leo J. Oguchi’s disease – Clinical image. Oman J Ophthalmol. 2023;16:567–9.
Google Scholar
Mizuo G. On a new discovery in the dark adaptation of Oguchi’s disease. Nippon Ganka Gakkai Zasshi (Acta Soc Ophthalmol Jpn). 1913;17:1148–50.
Gouras P. Electroretinography: some basic principles. Invest Ophthalmol. 1970;9:557–69.
Google Scholar
Sergouniotis PI, Davidson AE, Sehmi K, Webster AR, Robson AG, Moore AT. Mizuo-Nakamura phenomenon in Oguchi disease due to a homozygous nonsense mutation in the SAG gene. Eye (Lond). 2011;25:1098–101.
Google Scholar
Miyake Y, Horiguchi M, Suzuki S, Kondo M, Tanikawa A. Electrophysiological findings in patients with Oguchi’s disease. Jpn J Ophthalmol. 1996;40:511–9.
Google Scholar
Dryja TP. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson memorial lecture. Am J Ophthalmol. 2000;130:547–63.
Google Scholar
Sergouniotis PI, Sohn EH, Li Z, McBain VA, Wright GA, Moore AT, Robson AG, Holder GE, Webster AR. Phenotypic variability in RDH5 retinopathy (Fundus Albipunctatus). Ophthalmology. 2011;118:1661–70.
Google Scholar
Schubert G, Bornschein H. Beitrag Zur analyse des menschlichen elektroretinogramms. Ophthalmologica. 2010;123:396–413.
Google Scholar
Zeitz C, Robson AG, Audo I. Congenital stationary night blindness: an analysis and update of genotype–phenotype correlations and pathogenic mechanisms. Prog Retin Eye Res. 2015;45:58–110.
Google Scholar
AlTalbishi A, Zelinger L, Zeitz C, Hendler K, Namburi P, Audo I, Sheffer R, Yahalom C, Khateb S, Banin E, Sharon D. TRPM1 mutations are the most common cause of autosomal recessive congenital stationary night blindness (CSNB) in the Palestinian and Israeli populations. Sci Rep. 2019;9:12047.
Google Scholar
Miyake Y, Yagasaki K, Horiguchi M, Kawase Y. On- and off-responses in photopic electroretinogram in complete and incomplete types of congenital stationary night blindness. Jpn J Ophthalmol. 1987;31:81–7.
Google Scholar
Miyake Y, Yagasaki K, Horiguchi M, Kawase Y, Kanda T. Congenital stationary night blindness with negative electroretinogram: A new classification. Arch Ophthalmol. 1986;104:1013–20.
Google Scholar
Miyake Y. Establishment of the concept of new clinical entities–complete and incomplete form of congenital stationary night blindness. Nippon Ganka Gakkai Zasshi. 2002;106:737–56.
Google Scholar
Sustar M, Holder GE, Kremers J, Barnes CS, Lei B, Khan NW, Robson AG. ISCEV extended protocol for the photopic On-Off ERG. Doc Ophthalmol. 2018;136:199–206.
Google Scholar
Bijveld MM, Florijn RJ, Bergen AA, van den Born LI, Kamermans M, Prick L, Riemslag FC, van Schooneveld MJ, Kappers AM, van Genderen MM. Genotype and phenotype of 101 Dutch patients with congenital stationary night blindness. Ophthalmology. 2013;120:2072–81.
Google Scholar
Sergouniotis PI, Robson AG, Li Z, Devery S, Holder GE, Moore AT, Webster AR. A phenotypic study of congenital stationary night blindness (CSNB) associated with mutations in the GRM6 gene. Acta Ophthalmol. 2012;90:e192–197.
Google Scholar
Riggs LA. Electroretinography in cases of night blindness. Am J Ophthalmol. 1954;38:70–8.
Google Scholar
Marmor MF, Zeitz C. Riggs-type dominant congenital stationary night blindness: ERG findings, a new GNAT1 mutation and a systemic association. Doc Ophthalmol. 2018;137:57–62.
Google Scholar
Szabo V, Kreienkamp HJ, Rosenberg T, Gal A. p.Gln200Glu, a putative constitutively active mutant of rod alpha-transducin (GNAT1) in autosomal dominant congenital stationary night blindness. Hum Mutat. 2007;28:741–2.
Google Scholar
Naeem MA, Chavali VRM, Ali S, Iqbal M, Riazuddin S, Khan SN, Husnain T, Sieving PA, Ayyagari R, Riazuddin S, et al. GNAT1 associated with autosomal recessive congenital stationary night blindness. Invest Ophthalmol Vis Sci. 2012;53:1353–61.
Google Scholar
Zeitz C, Méjécase C, Stévenard M, Michiels C, Audo I, Marmor MF. A novel heterozygous missense mutation in GNAT1 leads to autosomal dominant Riggs type of congenital stationary night blindness. Biomed Res Int. 2018;2018:7694801.
Google Scholar
Vincent A, Audo I, Tavares E, Maynes JT, Tumber A, Wright T, Li S, Michiels C, Condroyer C, MacDonald H, et al. Biallelic mutations in GNB3 cause a unique form of Autosomal-Recessive congenital stationary night blindness. Am J Hum Genet. 2016;98:1011–9.
Google Scholar
Arno G, Holder GE, Chakarova C, Kohl S, Pontikos N, Fiorentino A, Plagnol V, Cheetham ME, Hardcastle AJ, Webster AR, Michaelides M. Recessive retinopathy consequent on mutant G-Protein Β subunit 3 (GNB3). JAMA Ophthalmol. 2016;134:924–7.
Google Scholar
Audo I, Robson AG, Holder GE, Moore AT. The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction. Surv Ophthalmol. 2008;53:16–40.
Google Scholar
Tsang SH, Woodruff ML, Jun L, Mahajan V, Yamashita CK, Pedersen R, Lin CS, Goff SP, Rosenberg T, Larsen M, et al. Transgenic mice carrying the H258N mutation in the gene encoding the beta-subunit of phosphodiesterase-6 (PDE6B) provide a model for human congenital stationary night blindness. Hum Mutat. 2007;28:243–54.
Google Scholar
Kobal N, Krašovec T, Šuštar M, Volk M, Peterlin B, Hawlina M, Fakin A. Stationary and progressive phenotypes caused by the p.G90D mutation in rhodopsin gene. Int J Mol Sci. 2021;22:2133.
Riazuddin SA, Shahzadi A, Zeitz C, Ahmed ZM, Ayyagari R, Chavali VR, Ponferrada VG, Audo I, Michiels C, Lancelot ME, et al. A mutation in SLC24A1 implicated in autosomal-recessive congenital stationary night blindness. Am J Hum Genet. 2010;87:523–31.
Google Scholar
Neuillé M, Malaichamy S, Vadalà M, Michiels C, Condroyer C, Sachidanandam R, Srilekha S, Arokiasamy T, Letexier M, Démontant V, et al. Next-generation sequencing confirms the implication of SLC24A1 in autosomal-recessive congenital stationary night blindness. Clin Genet. 2016;89:690–9.
Google Scholar
Dryja TP, Hahn LB, Reboul T, Arnaud B. Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet. 1996;13:358–60.
Google Scholar
Gal A, Xu S, Piczenik Y, Eiberg H, Duvigneau C, Schwinger E, Rosenberg T. Gene for autosomal dominant congenital stationary night blindness maps to the same region as the gene for the beta-subunit of the rod photoreceptor cGMP phosphodiesterase (PDEB) in chromosome 4p16.3. Hum Mol Genet. 1994;3:323–5.
Google Scholar
Manes G, Cheguru P, Majumder A, Bocquet B, Sénéchal A, Artemyev NO, Hamel CP, Brabet P. A truncated form of rod photoreceptor PDE6 β-subunit causes autosomal dominant congenital stationary night blindness by interfering with the inhibitory activity of the γ-subunit. PLoS ONE. 2014;9:e95768.
Google Scholar
Schöneberg T, Schulz A, Biebermann H, Hermsdorf T, Römpler H, Sangkuhl K. Mutant G-protein-coupled receptors as a cause of human diseases. Pharmacol Ther. 2004;104:173–206.
Google Scholar
You H, Sierpina D. A novel pathogenic variant in the RDH5 gene in a patient with fundus albipunctatus and severe macular atrophy. Case Rep Genet. 2022;2022:1183772.
Google Scholar
Fuchs S, Nakazawa M, Maw M, Tamai M, Oguchi Y, Gal A. A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet. 1995;10:360–2.
Google Scholar
Yamamoto S, Sippel KC, Berson EL, Dryja TP. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet. 1997;15:175–8.
Google Scholar
Ahnelt P, Keri C, Kolb H. Identification of pedicles of putative blue-sensitive cones in the human retina. J Comp Neurol. 1990;293:39–53.
Google Scholar
Haverkamp S, Grünert U, Wässle H. The cone pedicle, a complex synapse in the retina. Neuron. 2000;27:85–95.
Google Scholar
Wässle H. Parallel processing in the mammalian retina. Nat Rev Neurosci. 2004;5:747–57.
Google Scholar
Diamond JS. Inhibitory interneurons in the retina: types, circuitry, and function. Annu Rev Vis Sci. 2017;3:1–24.
Google Scholar
Strom TM, Nyakatura G, Apfelstedt-Sylla E, Hellebrand H, Lorenz B, Weber BH, Wutz K, Gutwillinger N, Rüther K, Drescher B, et al. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet. 1998;19:260–3.
Google Scholar
Bech-Hansen NT, Naylor MJ, Maybaum TA, Pearce WG, Koop B, Fishman GA, Mets M, Musarella MA, Boycott KM. Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat Genet. 1998;19:264–7.
Google Scholar
Zeitz C, Kloeckener-Gruissem B, Forster U, Kohl S, Magyar I, Wissinger B, Mátyás G, Borruat FX, Schorderet DF, Zrenner E, et al. Mutations in CABP4, the gene encoding the Ca2+-binding protein 4, cause autosomal recessive night blindness. Am J Hum Genet. 2006;79:657–67.
Google Scholar
Zeitz C, Michiels C, Neuillé M, Friedburg C, Condroyer C, Boyard F, Antonio A, Bouzidi N, Milicevic D, Veaux R, et al. Where are the missing gene defects in inherited retinal disorders? Intronic and synonymous variants contribute at least to 4% of CACNA1F-mediated inherited retinal disorders. Hum Mutat. 2019;40:765–87.
Google Scholar
Catterall WA. Structure and regulation of voltage-gated Ca2 + channels. Annu Rev Cell Dev Biol. 2000;16:521–55.
Google Scholar
Arikkath J, Campbell KP. Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol. 2003;13:298–307.
Google Scholar
Gurnett CA, De Waard M, Campbell KP. Dual function of the voltage-dependent Ca2 + channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron. 1996;16:431–40.
Google Scholar
Song H, Nie L, Rodriguez-Contreras A, Sheng ZH, Yamoah EN. Functional interaction of auxiliary subunits and synaptic proteins with Ca(v)1.3 May impart hair cell Ca2 + current properties. J Neurophysiol. 2003;89:1143–9.
Google Scholar
Shaltiel L, Paparizos C, Fenske S, Hassan S, Gruner C, Rötzer K, Biel M, Wahl-Schott CA. Complex regulation of voltage-dependent activation and inactivation properties of retinal voltage-gated Cav1.4 L-type Ca2 + channels by Ca2+-binding protein 4 (CaBP4). J Biol Chem. 2012;287:36312–21.
Google Scholar
Nakajima Y, Iwakabe H, Akazawa C, Nawa H, Shigemoto R, Mizuno N, Nakanishi S. Molecular characterization of a novel retinal metabotropic glutamate receptor mGluR6 with a high agonist selectivity for L-2-amino-4-phosphonobutyrate. J Biol Chem. 1993;268:11868–73.
Google Scholar
Nomura A, Shigemoto R, Nakamura Y, Okamoto N, Mizuno N, Nakanishi S. Developmentally regulated postsynaptic localization of a metabotropic glutamate receptor in rat rod bipolar cells. Cell. 1994;77:361–9.
Google Scholar
Masu M, Iwakabe H, Tagawa Y, Miyoshi T, Yamashita M, Fukuda Y, Sasaki H, Hiroi K, Nakamura Y, Shigemoto R, et al. Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell. 1995;80:757–65.
Google Scholar
Morgans CW, Zhang J, Jeffrey BG, Nelson SM, Burke NS, Duvoisin RM, Brown RL. TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci U S A. 2009;106:19174–8.
Google Scholar
Shen Y, Heimel JA, Kamermans M, Peachey NS, Gregg RG, Nawy S. A transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells. J Neurosci. 2009;29:6088–93.
Google Scholar
Koike C, Obara T, Uriu Y, Numata T, Sanuki R, Miyata K, Koyasu T, Ueno S, Funabiki K, Tani A, et al. TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A. 2010;107:332–7.
Google Scholar
Brandstätter JH, Koulen P, Wässle H. Diversity of glutamate receptors in the mammalian retina. Vis Res. 1998;38:1385–97.
Google Scholar
Puller C, Ivanova E, Euler T, Haverkamp S, Schubert T. OFF bipolar cells express distinct types of dendritic glutamate receptors in the mouse retina. Neuroscience. 2013;243:136–48.
Google Scholar
Ichinose T, Hellmer CB. Differential signalling and glutamate receptor compositions in the OFF bipolar cell types in the mouse retina. J Physiol. 2016;594:883–94.
Google Scholar
Nawy S. The metabotropic receptor mGluR6 May signal through G(o), but not phosphodiesterase, in retinal bipolar cells. J Neurosci. 1999;19:2938–44.
Google Scholar
Pearring JN, Bojang P Jr., Shen Y, Koike C, Furukawa T, Nawy S, Gregg RG. A role for Nyctalopin, a small leucine-rich repeat protein, in localizing the TRP melastatin 1 channel to retinal depolarizing bipolar cell dendrites. J Neurosci. 2011;31:10060–6.
Google Scholar
Neuillé M, Morgans CW, Cao Y, Orhan E, Michiels C, Sahel JA, Audo I, Duvoisin RM, Martemyanov KA, Zeitz C. LRIT3 is essential to localize TRPM1 to the dendritic tips of depolarizing bipolar cells and May play a role in cone synapse formation. Eur J Neurosci. 2015;42:1966–75.
Google Scholar
van Genderen MM, Bijveld MM, Claassen YB, Florijn RJ, Pearring JN, Meire FM, McCall MA, Riemslag FC, Gregg RG, Bergen AA, Kamermans M. Mutations in TRPM1 are a common cause of complete congenital stationary night blindness. Am J Hum Genet. 2009;85:730–6.
Google Scholar
Ray TA, Heath KM, Hasan N, Noel JM, Samuels IS, Martemyanov KA, Peachey NS, McCall MA, Gregg RG. GPR179 is required for high sensitivity of the mGluR6 signaling cascade in depolarizing bipolar cells. J Neurosci. 2014;34:6334–43.
Google Scholar
Dhingra A, Ramakrishnan H, Neinstein A, Fina ME, Xu Y, Li J, Chung DC, Lyubarsky A, Vardi N. Gβ3 is required for normal light ON responses and synaptic maintenance. J Neurosci. 2012;32:11343–55.
Google Scholar
Wycisk KA, Budde B, Feil S, Skosyrski S, Buzzi F, Neidhardt J, Glaus E, Nürnberg P, Ruether K, Berger W. Structural and functional abnormalities of retinal ribbon synapses due to Cacna2d4 mutation. Invest Ophthalmol Vis Sci. 2006;47:3523–30.
Google Scholar
Baehr W, Frederick JM. Naturally occurring animal models with outer retina phenotypes. Vis Res. 2009;49:2636–52.
Google Scholar
Chen-Tsai RY, Jiang R, Zhuang L, Wu J, Li L, Wu J. Genome editing and animal models. Chin Sci Bull. 2014;59:1–6.
Google Scholar
Devoy A, Bunton-Stasyshyn RKA, Tybulewicz VLJ, Smith AJH, Fisher EMC. Genomically humanized mice: technologies and promises. Nat Rev Genet. 2012;13:14–20.
Google Scholar
Scheer N, Snaith M, Wolf CR, Seibler J. Generation and utility of genetically humanized mouse models. Drug Discov Today. 2013;18:1200–11.
Google Scholar
Occelli LM, Daruwalla A, De Silva SR, Winkler PA, Sun K, Pasmanter N, Minella A, Querubin J, Lyons LA, Robson AG, et al. A large animal model of RDH5-associated retinopathy recapitulates important features of the human phenotype. Hum Mol Genet. 2022;31:1263–77.
Google Scholar
Das RG, Becker D, Jagannathan V, Goldstein O, Santana E, Carlin K, Sudharsan R, Leeb T, Nishizawa Y, Kondo M, et al. Genome-wide association study and whole-genome sequencing identify a deletion in LRIT3 associated with canine congenital stationary night blindness. Sci Rep. 2019;9:14166.
Google Scholar
Goldstein O, Jordan JA, Aguirre GD, Acland GM. A non-stop S-antigen gene mutation is associated with late onset hereditary retinal degeneration in dogs. Mol Vis. 2013;19:1871–84.
Google Scholar
Chen W, Zhong W, Yu L, Lin X, Xie J, Liu Z. A drosophila model reveals the potential role for Mtt in retinal disease. Int J Mol Sci. 2024;25:899.
Google Scholar
Hack YL, Crabtree EE, Avila F, Sutton RB, Grahn R, Oh A, Gilger B, Bellone RR. Whole-genome sequencing identifies missense mutation in GRM6 as the likely cause of congenital stationary night blindness in a Tennessee walking horse. Equine Vet J. 2021;53:316–23.
Google Scholar
Bellone RR, Archer S, Wade CM, Cuka-Lawson C, Haase B, Leeb T, Forsyth G, Sandmeyer L, Grahn B. Association analysis of candidate SNPs in TRPM1 with Leopard complex spotting (LP ) and congenital stationary night blindness (CSNB) in horses. Anim Genet. 2010;41:207–207.
Google Scholar
Orhan E, Neuillé M, de Sousa Dias M, Pugliese T, Michiels C, Condroyer C, Antonio A, Sahel J-A, Audo I, Zeitz C. A new mouse model for complete congenital stationary night blindness due to Gpr179 deficiency. Int J Mol Sci. 2021;22:4424.
Google Scholar
Neuillé M, El Shamieh S, Orhan E, Michiels C, Antonio A, Lancelot ME, Condroyer C, Bujakowska K, Poch O, Sahel JA, et al. Lrit3 deficient mouse (nob6): a novel model of complete congenital stationary night blindness (cCSNB). PLoS ONE. 2014;9:e90342.
Google Scholar
Dai X, Pang S, Wang J, FitzMaurice B, Pang J, Chang B. Photoreceptor degeneration in a new Cacna1f mutant mouse model. Exp Eye Res. 2019;179:106–14.
Google Scholar
Peachey NS, Hasan N, FitzMaurice B, Burrill S, Pangeni G, Karst SY, Reinholdt L, Berry ML, Strobel M, Gregg RG, et al. A missense mutation in Grm6 reduces but does not eliminate mGluR6 expression or rod depolarizing bipolar cell function. J Neurophysiol. 2017;118:845–54.
Google Scholar
Sieving PA, Fowler ML, Bush RA, Machida S, Calvert PD, Green DG, Makino CL, McHenry CL. Constitutive light adaptation in rods from G90D rhodopsin: A mechanism for human congenital nightblindness without rod cell loss. J Neurosci. 2001;21:5449–60.
Google Scholar
Moussaif M, Rubin WW, Kerov V, Reh R, Chen D, Lem J, Chen C-K, Hurley JB, Burns ME, Artemyev NO. Phototransduction in a Transgenic mouse model of Nougaret night blindness. J Neurosci. 2006;26:6863–72.
Google Scholar
Kerov V, Chen D, Moussaif M, Chen Y-J, Chen C-K, Artemyev NO. Transducin activation state controls its Light-dependent translocation in rod photoreceptors. J Biol Chem. 2005;280:41069–76.
Google Scholar
Calvert PD, Krasnoperova NV, Lyubarsky AL, Isayama T, Nicolo M, Kosaras B, Wong G, Gannon KS, Margolskee RF, Sidman RL. Phototransduction in Transgenic mice after targeted deletion of the rod transducin α-subunit. Proc Natl Acad Sci U S A. 2000;97:13913–8.
Google Scholar
Driessen CA, Winkens HJ, Hoffmann K, Kuhlmann LD, Janssen BP, Van Vugt AH, Van Hooser JP, Wieringa BE, Deutman AF, Palczewski K, et al. Disruption of the 11-cis-retinol dehydrogenase gene leads to accumulation of cis-retinols and cis-retinyl esters. Mol Cell Biol. 2000;20:4275–87.
Google Scholar
Chen CK, Burns ME, Spencer M, Niemi GA, Chen J, Hurley JB, Baylor DA, Simon MI. Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc Natl Acad Sci U S A. 1999;96:3718–22.
Google Scholar
Mansergh F, Orton NC, Vessey JP, Lalonde MR, Stell WK, Tremblay F, Barnes S, Rancourt DE, Bech-Hansen NT. Mutation of the calcium channel gene Cacna1f disrupts calcium signaling, synaptic transmission and cellular organization in mouse retina. Hum Mol Genet. 2005;14:3035–46.
Google Scholar
Doering CJ, Rehak R, Bonfield S, Peloquin JB, Stell WK, Mema SC, Sauvé Y, McRory JE. Modified Cav1.4 expression in the Cacna1fnob2 mouse due to alternative splicing of an ETn inserted in exon 2. PLoS ONE. 2008;3:e2538.
Google Scholar
Michalakis S, Shaltiel L, Sothilingam V, Koch S, Schludi V, Krause S, Zeitz C, Audo I, Lancelot M-E, Hamel C, et al. Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2. Hum Mol Genet. 2013;23:1538–50.
Google Scholar
Knoflach D, Kerov V, Sartori SB, Obermair GJ, Schmuckermair C, Liu X, Sothilingam V, Garrido MG, Baker SA, Glösmann M, et al. Cav1.4 IT mouse as model for vision impairment in human congenital stationary night blindness type 2. Channels. 2013;7:503–13.
Google Scholar
Haeseleer F, Imanishi Y, Maeda T, Possin DE, Maeda A, Lee A, Rieke F, Palczewski K. Essential role of Ca2+-binding protein 4, a Cav1.4 channel regulator, in photoreceptor synaptic function. Nat Neurosci. 2004;7:1079–87.
Google Scholar
Peachey NS, Pearring JN, Bojang P Jr., Hirschtritt ME, Sturgill-Short G, Ray TA, Furukawa T, Koike C, Goldberg AF, Shen Y, et al. Depolarizing bipolar cell dysfunction due to a Trpm1 point mutation. J Neurophysiol. 2012;108:2442–51.
Google Scholar
Koyasu T, Kondo M, Miyata K, Ueno S, Miyata T, Nishizawa Y, Terasaki H. Photopic electroretinograms of mGluR6-deficient mice. Curr Eye Res. 2008;33:91–9.
Google Scholar
Maddox DM, Vessey KA, Yarbrough GL, Invergo BM, Cantrell DR, Inayat S, Balannik V, Hicks WL, Hawes NL, Byers S, et al. Allelic variance between GRM6 mutants, Grm6nob3 and Grm6nob4 results in differences in retinal ganglion cell visual responses. J Physiol. 2008;586:4409–24.
Google Scholar
Peachey Neal S, Ray Thomas A, Florijn R, Rowe Lucy B, Sjoerdsma T, Contreras-Alcantara S, Baba K, Tosini G, Pozdeyev N, Iuvone PM, et al. GPR179 is required for depolarizing bipolar cell function and is mutated in Autosomal-Recessive complete congenital stationary night blindness. Am J Hum Genet. 2012;90:331–9.
Google Scholar
Qian H, Ji R, Gregg RG, Peachey NS. Identification of a new mutant allele, Grm6(nob7), for complete congenital stationary night blindness. Vis Neurosci. 2015;32:E004.
Google Scholar
Chai Z, Ye Y, Silverman D, Rose K, Madura A, Reed RR, Chen J, Yau K-W. Dark continuous noise from mutant G90D-rhodopsin predominantly underlies congenital stationary night blindness. Proc Natl Acad Sci U S A. 2024;121:e2404763121.
Google Scholar
An J, Wang L, Guo Q, Li L, Xia F, Zhang Z. Behavioral phenotypic properties of a natural occurring rat model of congenital stationary night blindness with Cacna1f mutation. J Neurogenet. 2012;26:363–73.
Google Scholar
Jia S, Muto A, Orisme W, Henson HE, Parupalli C, Ju B, Baier H, Taylor MR. Zebrafish Cacna1fa is required for cone photoreceptor function and synaptic ribbon formation. Hum Mol Genet. 2014;23:2981–94.
Google Scholar
Muto A, Orger MB, Wehman AM, Smear MC, Kay JN, Page-McCaw PS, Gahtan E, Xiao T, Nevin LM, Gosse NJ, et al. Forward genetic analysis of visual behavior in zebrafish. PLoS Genet. 2005;1:e66.
Google Scholar
Bahadori R, Biehlmaier O, Zeitz C, Labhart T, Makhankov YV, Forster U, Gesemann M, Berger W, Neuhauss SCF. Nyctalopin is essential for synaptic transmission in the cone dominated zebrafish retina. Eur J Neurosci. 2006;24:1664–74.
Google Scholar
Huang Y-Y, Haug MF, Gesemann M, Neuhauss SCF. Novel expression patterns of metabotropic glutamate receptor 6 in the zebrafish nervous system. PLoS ONE. 2012;7:e35256.
Google Scholar
Whalen M, Akula M, McNamee SM, DeAngelis MM, Haider NB. Seeing the future: A review of ocular therapy. Bioeng (Basel). 2024;11:179.
Google Scholar
Segurado OG, Jiang R, Pipe SW. Challenges and opportunities when transitioning from in vivo gene replacement to in vivo CRISPR/Cas9 therapies – a spotlight on hemophilia. Expert Opin Biol Ther. 2022;22:1091–8.
Google Scholar
Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157:1262–78.
Google Scholar
Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol. 2014;32:347–55.
Google Scholar
Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346:1258096.
Google Scholar
Cox DB, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015;21:121–31.
Google Scholar
McVey M, Lee SE. MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings. Trends Genet. 2008;24:529–38.
Google Scholar
Suzuki K, Tsunekawa Y, Hernandez-Benitez R, Wu J, Zhu J, Kim EJ, Hatanaka F, Yamamoto M, Araoka T, Li Z, et al. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration. Nature. 2016;540:144–9.
Google Scholar
Suzuki K, Yamamoto M, Hernandez-Benitez R, Li Z, Wei C, Soligalla RD, Aizawa E, Hatanaka F, Kurita M, Reddy P, et al. Precise in vivo genome editing via single homology arm donor mediated intron-targeting gene integration for genetic disease correction. Cell Res. 2019;29:804–19.
Google Scholar
Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. 2016;533:420–4.
Google Scholar
Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature. 2017;551:464–71.
Google Scholar
Anzalone AV, Koblan LW, Liu DR. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol. 2020;38:824–44.
Google Scholar
Pacesa M, Pelea O, Jinek M. Past, present, and future of CRISPR genome editing technologies. Cell. 2024;187:1076–100.
Google Scholar
Tong H, Wang H, Wang X, Liu N, Li G, Wu D, Li Y, Jin M, Li H, Wei Y, et al. Development of deaminase-free T-to-S base editor and C-to-G base editor by engineered human uracil DNA glycosylase. Nat Commun. 2024;15:4897.
Google Scholar
Yan AL, Du SW, Palczewski K. Genome editing, a superior therapy for inherited retinal diseases. Vis Res. 2023;206:108192.
Google Scholar
Doman JL, Pandey S, Neugebauer ME, An M, Davis JR, Randolph PB, McElroy A, Gao XD, Raguram A, Richter MF, et al. Phage-assisted evolution and protein engineering yield compact, efficient prime editors. Cell. 2023;186:3983–4002. e3926.
Google Scholar
Maeder ML, Shen S, Burnight ER, Gloskowski S, Mepani R, Friedland AE, Jayaram H, Gotta G, Tucker BA, Bumcrot D. 687. Therapeutic correction of an LCA-Causing splice defect in the CEP290 gene by CRISPR/Cas-Mediated genome editing. Mol Ther. 2015;23:S273–4.
Google Scholar
Pierce EA, Aleman TS, Jayasundera KT, Ashimatey BS, Kim K, Rashid A, Jaskolka MC, Myers RL, Lam BL, Bailey ST. Gene editing for CEP290-associated retinal degeneration. N Engl J Med. 2024;390:1972–84.
Google Scholar
Szabó V, Varsányi B, Barboni M, Takács Á, Knézy K, Molnár MJ, Nagy ZZ, György B, Rivolta C. Insights into eye genetics and recent advances in ocular gene therapy. Mol Cell Probes. 2025;79:102008.
Google Scholar
Xue K, MacLaren RE. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases. Expert Opin Investig Drugs. 2020;29:1163–70.
Google Scholar
Quemener AM, Bachelot L, Forestier A, Donnou-Fournet E, Gilot D, Galibert MD. The powerful world of antisense oligonucleotides: from bench to bedside. Wiley Interdiscip Rev RNA. 2020;11:e1594.
Google Scholar
Vázquez-Domínguez I, Anido AA, Duijkers L, Hoppenbrouwers T, Hoogendoorn ADM, Koster C, Collin RWJ, Garanto A. Efficacy, biodistribution and safety comparison of chemically modified antisense oligonucleotides in the retina. Nucleic Acids Res. 2024;52:10447–63.
Google Scholar
Russell SR, Drack AV, Cideciyan AV, Jacobson SG, Leroy BP, Van Cauwenbergh C, Ho AC, Dumitrescu AV, Han IC, Martin M, et al. Intravitreal antisense oligonucleotide Sepofarsen in leber congenital amaurosis type 10: a phase 1b/2 trial. Nat Med. 2022;28:1014–21.
Google Scholar
Chi X, Gatti P, Papoian T. Safety of antisense oligonucleotide and siRNA-based therapeutics. Drug Discov Today. 2017;22:823–33.
Google Scholar
Gemayel MC, Bhatwadekar AD, Ciulla T. RNA therapeutics for retinal diseases. Expert Opin Biol Ther. 2021;21:603–13.
Google Scholar
Wen L, Liu Y, Yang Z, Mei S, Xin Y, Li S. Novel CACNA1F pathogenic variant in pediatric incomplete X-linked CSNB: integrating portable ERG and genetic analysis. Doc Ophthalmol. 2024;150:33–9.
Google Scholar
Bai D, Guo R, Huang D, Ji J, Liu W. Compound heterozygous mutations in GRM6 causing complete Schubert-Bornschein type congenital stationary night blindness. Heliyon. 2024;10:e27039.
Google Scholar
Smirnov VM, Robert MP, Condroyer C, Navarro J, Antonio A, Rozet JM, Sahel JA, Perrault I, Audo I, Zeitz C. Association of missense variants in VSX2 with a peculiar form of congenital stationary night blindness affecting all bipolar cells. JAMA Ophthalmol. 2022;140:1163–73.
Google Scholar
Ross M, Ofri R. The future of retinal gene therapy: evolving from subretinal to intravitreal vector delivery. Neural Regen Res. 2021;16:1751–9.
Google Scholar
Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Mol Vis. 2008;14:1760–9.
Google Scholar
Kotterman MA, Yin L, Strazzeri JM, Flannery JG, Merigan WH, Schaffer DV. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates. Gene Ther. 2015;22:116–26.
Google Scholar
Dalkara D, Kolstad KD, Caporale N, Visel M, Klimczak RR, Schaffer DV, Flannery JG. Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous. Mol Ther. 2009;17:2096–102.
Google Scholar
Dalkara D, Byrne LC, Klimczak RR, Visel M, Yin L, Merigan WH, Flannery JG, Schaffer DV. In vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous. Sci Transl Med. 2013;5:189ra176.
Google Scholar
Wert KJ, Skeie JM, Davis RJ, Tsang SH, Mahajan VB. Subretinal injection of gene therapy vectors and stem cells in the perinatal mouse eye. J Vis Exp. 2012;69:4286.
Munis AM. Gene therapy applications of Non-Human lentiviral vectors. Viruses. 2020;12:1106.
Wold WS, Toth K. Adenovirus vectors for gene therapy, vaccination and cancer gene therapy. Curr Gene Ther. 2013;13:421–33.
Google Scholar
Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther. 2006;14:316–27.
Google Scholar
Frederick A, Sullivan J, Liu L, Adamowicz M, Lukason M, Raymer J, Luo Z, Jin X, Rao KN. O’Riordan C. Engineered capsids for efficient gene delivery to the retina and cornea. Hum Gene Ther. 2020;31:756–74.
Google Scholar
Song H, Bush RA, Zeng Y, Qian H, Wu Z, Sieving PA. Trans-ocular electric current in vivo enhances AAV-Mediated retinal gene transduction after intravitreal vector administration. Mol Ther Methods Clin Dev. 2019;13:77–85.
Google Scholar
Lebherz C, Maguire A, Tang W, Bennett J, Wilson JM. Novel AAV serotypes for improved ocular gene transfer. J Gene Med. 2008;10:375–82.
Google Scholar
Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18:358–78.
Google Scholar
Bartel MA, Weinstein JR, Schaffer DV. Directed evolution of novel adeno-associated viruses for therapeutic gene delivery. Gene Ther. 2012;19:694–700.
Google Scholar
Cronin T, Vandenberghe LH, Hantz P, Juttner J, Reimann A, Kacsó AE, Huckfeldt RM, Busskamp V, Kohler H, Lagali PS, et al. Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter. EMBO Mol Med. 2014;6:1175–90.
Google Scholar
Ramachandran PS, Lee V, Wei Z, Song JY, Casal G, Cronin T, Willett K, Huckfeldt R, Morgan JI, Aleman TS, et al. Evaluation of dose and safety of AAV7m8 and AAV8BP2 in the Non-Human primate retina. Hum Gene Ther. 2017;28:154–67.
Google Scholar
Luo S, Jiang H, Li Q, Qin Y, Yang S, Li J, Xu L, Gou Y, Zhang Y, Liu F, et al. An adeno-associated virus variant enabling efficient ocular-directed gene delivery across species. Nat Commun. 2024;15:3780.
Google Scholar
Trapani I, Colella P, Sommella A, Iodice C, Cesi G, de Simone S, Marrocco E, Rossi S, Giunti M, Palfi A, et al. Effective delivery of large genes to the retina by dual AAV vectors. EMBO Mol Med. 2014;6:194–211.
Google Scholar
Maddalena A, Tornabene P, Tiberi P, Minopoli R, Manfredi A, Mutarelli M, Rossi S, Simonelli F, Naggert JK, Cacchiarelli D, Auricchio A. Triple vectors expand AAV transfer capacity in the retina. Mol Ther. 2018;26:524–41.
Google Scholar
Dyka FM, Boye SL, Chiodo VA, Hauswirth WW, Boye SE. Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A. Hum Gene Ther Methods. 2014;25:166–77.
Google Scholar
Trapani I, Toriello E, de Simone S, Colella P, Iodice C, Polishchuk EV, Sommella A, Colecchi L, Rossi S, Simonelli F, et al. Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease. Hum Mol Genet. 2015;24:6811–25.
Google Scholar
Davis JR, Wang X, Witte IP, Huang TP, Levy JM, Raguram A, Banskota S, Seidah NG, Musunuru K, Liu DR. Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors. Nat Biomed Eng. 2022;6:1272–83.
Google Scholar
Zhang H, Bamidele N, Liu P, Ojelabi O, Gao XD, Rodriguez T, Cheng H, Kelly K, Watts JK, Xie J, et al. Adenine base editing in vivo with a single Adeno-Associated virus vector. GEN Biotechnol. 2022;1:285–99.
Google Scholar
Vandenberghe LH, Bell P, Maguire AM, Cearley CN, Xiao R, Calcedo R, Wang L, Castle MJ, Maguire AC, Grant R, et al. Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey. Sci Transl Med. 2011;3:88ra54.
Google Scholar
Le HT, Yu QC, Wilson JM, Croyle MA. Utility of pegylated Recombinant adeno-associated viruses for gene transfer. J Control Release. 2005;108:161–77.
Google Scholar
Yao T, Zhou X, Zhang C, Yu X, Tian Z, Zhang L, Zhou D. Site-specific pegylated Adeno-associated viruses with increased serum stability and reduced immunogenicity. Molecules. 2017;22:1155.
Google Scholar
Mingozzi F, Anguela XM, Pavani G, Chen Y, Davidson RJ, Hui DJ, Yazicioglu M, Elkouby L, Hinderer CJ, Faella A, et al. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci Transl Med. 2013;5:194ra192.
Google Scholar
Manservigi R, Argnani R, Marconi P. HSV Recombinant vectors for gene therapy. Open Virol J. 2010;4:123–56.
Google Scholar
Zhao Z, Anselmo AC, Mitragotri S. Viral vector-based gene therapies in the clinic. Bioeng Transl Med. 2022;7:e10258.
Google Scholar
Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the Art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001;7:33–40.
Google Scholar
de Silva S, Bowers WJ. Targeting the central nervous system with herpes simplex virus / Sleeping beauty hybrid amplicon vectors. Curr Gene Ther. 2011;11:332–40.
Google Scholar
Yang M, Gao Y, Li M, Cao X, Huang X. Attenuated herpes simplex virus 1 vector expressing Oncomodulin effectively allieviates mechanical optic nerve injury in rats. Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:1448–55.
Google Scholar
Kuzmin DA, Shutova MV, Johnston NR, Smith OP, Fedorin VV, Kukushkin YS, van der Loo JCM, Johnstone EC. The clinical landscape for AAV gene therapies. Nat Rev Drug Discov. 2021;20:173–4.
Google Scholar
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–16.
Google Scholar
Ryals RC, Patel S, Acosta C, McKinney M, Pennesi ME, Sahay G. The effects of pegylation on LNP based mRNA delivery to the eye. PLoS ONE. 2020;15:e0241006.
Google Scholar
Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, Brown D, Alkilany AM, Farokhzad OC, Mahmoudi M. Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev. 2017;46:4218–44.
Google Scholar
Skowronski DM, De Serres G. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2021;384:1576–7.
Google Scholar
Kulkarni JA, Witzigmann D, Thomson SB, Chen S, Leavitt BR, Cullis PR, van der Meel R. The current landscape of nucleic acid therapeutics. Nat Nanotechnol. 2021;16:630–43.
Google Scholar
Sabnis S, Kumarasinghe ES, Salerno T, Mihai C, Ketova T, Senn JJ, Lynn A, Bulychev A, McFadyen I, Chan J, et al. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained Pharmacology and safety in Non-human primates. Mol Ther. 2018;26:1509–19.
Google Scholar
Gautam M, Jozic A, Su GL-N, Herrera-Barrera M, Curtis A, Arrizabalaga S, Tschetter W, Ryals RC, Sahay G. Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nat Commun. 2023;14:6468.
Google Scholar
Herrera-Barrera M, Ryals RC, Gautam M, Jozic A, Landry M, Korzun T, Gupta M, Acosta C, Stoddard J, Reynaga R. Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates. Sci Adv. 2023;9:eadd4623.
Google Scholar
Chambers CZ, Soo GL, Engel AL, Glass IA, Frassetto A, Martini PGV, Cherry TJ. Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues. Transl Vis Sci Technol. 2024;13:7.
Google Scholar
Li M, Liu Z, Wang D, Ye J, Shi Z, Pan C, Zhang Q, Ju R, Zheng Y, Liu Y. Intraocular mRNA delivery with endogenous MmPEG10-based virus-like particles. Exp Eye Res. 2024;243:109899.
Google Scholar
Raguram A, Banskota S, Liu DR. Therapeutic in vivo delivery of gene editing agents. Cell. 2022;185:2806–27.
Google Scholar
Banskota S, Raguram A, Suh S, Du SW, Davis JR, Choi EH, Wang X, Nielsen SC, Newby GA, Randolph PB, et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell. 2022;185:250–65.
Google Scholar
Mangeot PE, Risson V, Fusil F, Marnef A, Laurent E, Blin J, Mournetas V, Massouridès E, Sohier TJM, Corbin A, et al. Genome editing in primary cells and in vivo using viral-derived nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat Commun. 2019;10:45.
Google Scholar
An M, Raguram A, Du SW, Banskota S, Davis JR, Newby GA, Chen PZ, Palczewski K, Liu DR. Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo. Nat Biotechnol. 2024;42:1526–37.
Google Scholar
Jiang Z, Dalby PA. Challenges in scaling up AAV-based gene therapy manufacturing. Trends Biotechnol. 2023;41:1268–81.
Google Scholar
Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, Sharf-Pauker N, Xiao Y, Adir O, Liang H, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022;2:24.
Google Scholar
Patel S, Ryals RC, Weller KK, Pennesi ME, Sahay G. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91–100.
Google Scholar
Kay CN, Ryals RC, Aslanidi GV, Min SH, Ruan Q, Sun J, Dyka FM, Kasuga D, Ayala AE, Van Vliet K, et al. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors. PLoS ONE. 2013;8:e62097.
Google Scholar
de Leeuw CN, Dyka FM, Boye SL, Laprise S, Zhou M, Chou AY, Borretta L, McInerny SC, Banks KG, Portales-Casamar E, et al. Targeted CNS delivery using human minipromoters and demonstrated compatibility with Adeno-Associated viral vectors. Mol Ther Methods Clin Dev. 2014;1:5.
Google Scholar
Gregg RG, Kamermans M, Klooster J, Lukasiewicz PD, Peachey NS, Vessey KA, McCall MA. Nyctalopin expression in retinal bipolar cells restores visual function in a mouse model of complete X-linked congenital stationary night blindness. J Neurophysiol. 2007;98:3023–33.
Google Scholar
Scalabrino ML, Boye SL, Fransen KM, Noel JM, Dyka FM, Min SH, Ruan Q, De Leeuw CN, Simpson EM, Gregg RG, et al. Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. Hum Mol Genet. 2015;24:6229–39.
Google Scholar
Hasan N, Pangeni G, Cobb CA, Ray TA, Nettesheim ER, Ertel KJ, Lipinski DM, McCall MA, Gregg RG. Presynaptic expression of LRIT3 transsynaptically organizes the postsynaptic glutamate signaling complex containing TRPM1. Cell Rep. 2019;27:3107–316.
Google Scholar
Allocca M, Mussolino C, Garcia-Hoyos M, Sanges D, Iodice C, Petrillo M, Vandenberghe LH, Wilson JM, Marigo V, Surace EM, Auricchio A. Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J Virol. 2007;81:11372–80.
Google Scholar
Morgans CW, Brown RL, Duvoisin RM. TRPM1: the endpoint of the mGluR6 signal transduction cascade in retinal ON-bipolar cells. BioEssays. 2010;32:609–14.
Google Scholar
Macé E, Caplette R, Marre O, Sengupta A, Chaffiol A, Barbe P, Desrosiers M, Bamberg E, Sahel JA, Picaud S, et al. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV restores ON and OFF visual responses in blind mice. Mol Ther. 2015;23:7–16.
Google Scholar
Varin J, Bouzidi N, Dias MMS, Pugliese T, Michiels C, Robert C, Desrosiers M, Sahel JA, Audo I, Dalkara D, Zeitz C. Restoration of mGluR6 localization following AAV-Mediated delivery in a mouse model of congenital stationary night blindness. Invest Ophthalmol Vis Sci. 2021;62:24.
Google Scholar
Khani SC, Pawlyk BS, Bulgakov OV, Kasperek E, Young JE, Adamian M, Sun X, Smith AJ, Ali RR, Li T. AAV-mediated expression targeting of rod and cone photoreceptors with a human rhodopsin kinase promoter. Invest Ophthalmol Vis Sci. 2007;48:3954–61.
Google Scholar
Varin J, Bouzidi N, Gauvain G, Joffrois C, Desrosiers M, Robert C, De Sousa Dias MM, Neuillé M, Michiels C, Nassisi M, et al. Substantial restoration of night vision in adult mice with congenital stationary night blindness. Mol Ther Methods Clin Dev. 2021;22:15–25.
Google Scholar
Kondo M, Das G, Imai R, Santana E, Nakashita T, Imawaka M, Ueda K, Ohtsuka H, Sakai K, Aihara T, et al. A naturally occurring canine model of autosomal recessive congenital stationary night blindness. PLoS ONE. 2015;10:e0137072.
Google Scholar
Lu Q, Ganjawala TH, Ivanova E, Cheng JG, Troilo D, Pan ZH. AAV-mediated transduction and targeting of retinal bipolar cells with improved mGluR6 promoters in rodents and primates. Gene Ther. 2016;23:680–9.
Google Scholar
Miyadera K, Santana E, Roszak K, Iffrig S, Visel M, Iwabe S, Boyd RF, Bartoe JT, Sato Y, Gray A, et al. Targeting ON-bipolar cells by AAV gene therapy stably reverses LRIT3-congenital stationary night blindness. Proc Natl Acad Sci U S A. 2022;119:e2117038119.
Google Scholar
Takahashi K, Kwok JC, Sato Y, Aguirre GD, Miyadera K. Extended functional rescue following AAV gene therapy in a canine model of LRIT3-congenital stationary night blindness. Vis Res. 2023;209:108260.
Google Scholar
link
